Janus Living, Inc.
JAN News Today: Stay Updated with the Latest Janus Living, Inc. News in Real Time
Find JAN news now at Meyka AI. Stay informed with the latest Janus Living, Inc. stocks updates, including price news, market analysis, and expert insights.
Globalway Inc. (3936.T) Surges 32% on Earnings Announcement
Globalway Inc. (3936.T) jumps 32% to ¥206 on May 14 earnings announcement. Tokyo tech firm gains on platform and IT services growth.
Healwell AI Inc. (AIDX.TO) Holds Steady at C$0.89 Amid Healthcare AI Push
AIDX.TO stock trades flat at C$0.89. Healwell AI focuses on preventative care AI platform with WELL Health partnership. Market cap C$267M.
Decidr AI Industries (DAI.AX) Climbs 1.5% as AI Software Platform Gains Traction
DAI.AX stock rises 1.5% to A$0.67 on growing AI software platform momentum. Track Decidr AI Industries on ASX today.
OECD Consumption Tax May 14: Japan Faces 18% Hike Proposal
OECD recommends Japan raise consumption tax to 18% gradually to fund aging society and improve fiscal sustainability amid demographic challenges.
OncoTherapy Science (4564.T) Faces Headwinds as Biotech Stock Slides 12.5% in Five Days
4564.T stock drops 12.5% over five days amid clinical trial pipeline challenges. Meyka AI rates the biotech firm with a B grade.
KMFI Stock Crashes 96% as Keller Manufacturing Faces Severe Liquidity Crisis
KMFI stock plummets 96.31% to $0.001 as Keller Manufacturing battles negative cash flow and minimal market cap of $6,576.
Steep Hill Inc. (STPH.CN) Holds Steady at C$0.055 Amid Cannabis Testing Demand
STPH.CN stock trades flat at C$0.055. Cannabis testing firm Steep Hill Inc. shows resilience with strong liquidity and upcoming earnings announcement.
Nisshinbo Holdings (3105.T) Surges 8.6% on Strong Technical Momentum
3105.T stock jumps 8.6% to ¥2,418 on overbought RSI and strong trend signals. Meyka AI rates the conglomerate with a B grade.
Genocea Biosciences Stock Collapses 97% as GNCA Faces Bankruptcy Aftermath
GNCA stock plummets 97.44% to $0.0001 following Chapter 11 bankruptcy filing. Genocea Biosciences faces severe delisting risk on NASDAQ.